Intersection of Hippo/YAP and Wnt/β-catenin signaling pathways

Acta Biochimica et Biophysica Sinica

Volumn 45, Issue 2, 2013, Pages 71-79

  Konsavage Jr , Wesley M ^a   Yochum, Gregory S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer; Hippo signaling; Tissue repair; Wnt catenin signaling

Indexed keywords

DROSOPHILA PROTEIN; HPO PROTEIN, DROSOPHILA; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; YORKIE PROTEIN, DROSOPHILA; YY1AP1 PROTEIN, HUMAN;

ANIMAL; HOMEOSTASIS; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; REGENERATION; REVIEW; WNT SIGNALING PATHWAY;

ANIMALS; DROSOPHILA PROTEINS; HOMEOSTASIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; REGENERATION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; WNT SIGNALING PATHWAY;

MLCS; MLOWN;

EID: 84881239237     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms084     Document Type: Review

References (111)

1. Sancho E, Batlle E and Clevers H. Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 2004, 20: 695-723.
2. Clevers H and Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012, 149: 1192-1205.
3. Zhao B, Tumaneng K and Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011, 13: 877-883.
4. Pan D. Hippo signaling in organ size control. Genes Dev 2007, 21: 886-897.
5. Sharma RP. Wingless, a New Mutant in Drosophila melanogaster. Drosophila Information Service, 1973, 50: 134.
6. Sharma RP and Chopra VL. Effect of the Wingless (wg1) mutation on wing and haltere development in Drosophila melanogaster. Dev Biol 1976, 48: 461-465.
7. Nusslein-Volhard C and Wieschaus E. Mutations affecting segment number and polarity in Drosophila. Nature 1980, 287: 795-801.
8. Nusse R and Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982, 31: 99-109.
9. Cabrera CV, Alonso MC, Johnston P, Phillips RG and Lawrence PA. Phenocopies induced with antisense RNA identify the wingless gene. Cell 1987, 50: 659-663.
10. Rijsewijk F, Schuermann M, Wagenaar E, Parren P, Weigel D and Nusse R. The Drosophila homolog of the mouse mammary oncogene int-1 is identical to the segment polarity gene wingless. Cell 1987, 50: 649-657.
11. Nusse R. Wnt signaling in disease and in development. Cell Res 2005, 15: 28-32.
12. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR and Munemitsu S, et al. Association of the APC gene product with betacatenin. Science 1993, 262: 1731-1734.
13. Su LK, Vogelstein B and Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993, 262: 1734-1737.
14. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL, 3rd and Lee JJ, et al. The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell 1997, 90: 181-192.
15. Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R and Kühl M, et al. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998, 280: 596-599.
16. Peters JM, McKay RM, McKay JP and Graff JM. Casein kinase I transduces Wnt signals. Nature 1999, 401: 345-350.
17. Hart MJ, de los Santos R, Albert IN, Rubinfeld B and Polakis P. Downregulation of beta-catenin by human Axin and its association with the APC tumor suppressor, beta-catenin and GSK3 beta. Curr Biol 1998, 8: 573-581.
18. Itoh K, Krupnik VE and Sokol SY. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 and beta-catenin. Curr Biol 1998, 8: 591-594.
19. Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y and Zhang Z, et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108: 837-847.
20. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R and Okamura H, et al. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation. Nature 2005, 438: 873-877.
21. Aberle H, Bauer A, Stappert J, Kispert A and Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997, 16: 3797-3804.
22. Marikawa Y and Elinson RP. beta-TrCP is a negative regulator of Wnt/ beta-catenin signaling pathway and dorsal axis formation in Xenopus embryos. Mech Dev 1998, 77: 75-80.
23. Gottardi CJ and Gumbiner BM. Distinct molecular forms of beta-catenin are targeted to adhesive or transcriptional complexes. J Cell Biol 2004, 167: 339-349.
24. Cavallo RA, Cox RT, Moline MM, Roose J, Polevoy GA, Clevers H and Peifer M, et al. Drosophila Tcf and Groucho interact to repress Wingless signalling activity. Nature 1998, 395: 604-608.
25. Brantjes H, Roose J, van De Wetering M and Clevers H. All Tcf HMG box transcription factors interact with Groucho-related co-repressors. Nucleic Acids Res 2001, 29: 1410-1419.
26. Cong F, Schweizer L and Varmus H. Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development 2004, 131: 5103-5115.
27. Cliffe A, Hamada F and Bienz M. A role of Dishevelled in relocating Axin to the plasma membrane during wingless signaling. Curr Biol 2003, 13: 960-966.
28. Bilic J, Huang YL, Davidson G, Zimmermann T, Cruciat CM, Bienz M and Niehrs C. Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. Science 2007, 316: 1619-1622.
29. Benchabane H, Hughes EG, Takacs CM, Baird JR and Ahmed Y. Adenomatous polyposis coli is present near the minimal level required for accurate graded responses to the Wingless morphogen. Development 2008, 135: 963-971.
30. Miyagishi M, Fujii R, Hatta M, Yoshida E, Araya N, Nagafuchi A and Ishihara S, et al. Regulation of Lef-mediated transcription and p53-dependent pathway by associating beta-catenin with CBP/p300. J Biol Chem 2000, 275: 35170-35175.
31. Barker N, Hurlstone A, Musisi H, Miles A, Bienz M and Clevers H. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J 2001, 20: 4935-4943.
32. Justice RW, Zilian O, Woods DF, Noll M and Bryant PJ. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 1995, 9: 534-546.
33. Xu T, Wang W, Zhang S, Stewart RA and Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. Development 1995, 121: 1053-1063.
34. Wu S, Huang J, Dong J and Pan D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 2003, 114: 445-456.
35. Udan RS, Kango-Singh M, Nolo R, Tao C and Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol 2003, 5: 914-920.
36. Harvey KF, Pfleger CM and Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 2003, 114: 457-467.
37. Pantalacci S, Tapon N and Leopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol 2003, 5: 921-927.
38. Jia J, Zhang W, Wang B, Trinko R and Jiang J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev 2003, 17: 2514-2519.
39. Kango-Singh M, Nolo R, Tao C, Verstreken P, Hiesinger PR, Bellen HJ and Halder G. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 2002, 129: 5719-5730.
40. Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber DA and Hariharan IK. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 2002, 110: 467-478.
41. Lai ZC, Wei X, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N and Ho LL, et al. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 2005, 120: 675-685.
42. Huang J, Wu S, Barrera J, Matthews K and Pan D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 2005, 122: 421-434.
43. Goulev Y, Fauny JD, Gonzalez-Marti B, Flagiello D, Silber J and Zider A. SCALLOPED interacts with YORKIE, the nuclear effector of the hippo tumor-suppressor pathway in Drosophila. Curr Biol 2008, 18: 435-441.
44. Wu S, Liu Y, Zheng Y, Dong J and Pan D. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell 2008, 14: 388-398.
45. Zhang L, Ren F, Zhang Q, Chen Y, Wang B and Jiang J. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control. Dev Cell 2008, 14: 377-387.
46. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D and Kreger BT, et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 2011, 144: 782-795.
47. Hwang E, Ryu KS, Paakkonen K, Guntert P, Cheong HK, Lim DS and Lee JO, et al. Structural insight into dimeric interaction of the SARAH domains from Mst1 and RASSF family proteins in the apoptosis pathway. Proc Natl Acad Sci USA 2007, 104: 9236-9241.
48. Praskova M, Xia F and Avruch J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr Biol 2008, 18: 311-321.
49. Wei X, Shimizu T and Lai ZC. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J 2007, 26: 1772-1781.
50. Park BH and Lee YH. Phosphorylation of SAV1 by mammalian ste20-like kinase promotes cell death. BMB Rep 2011, 44: 584-589.
51. Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J and Xie J, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 2007, 21: 2747-2761.
52. Basu S, Totty NF, Irwin MS, Sudol M and Downward J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol Cell 2003, 11: 11-23.
53. Zhao B, Li L, Tumaneng K, Wang CY and Guan KL. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 2010, 24: 72-85.
54. Liu CY, Zha ZY, Zhou X, Zhang H, Huang W, Zhao D and Li T, et al. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF beta-TrCP E3 ligase. J Biol Chem 2010, 285: 37159-37169.
55. Zhao B, Ye X, Yu J, Li L, Li W, Li S and Yu J, et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 2008, 22: 1962-1971.
56. Matakatsu H and Blair SS. Separating the adhesive and signaling functions of the Fat and Dachsous protocadherins. Development 2006, 133: 2315-2324.
57. Rogulja D, Rauskolb C and Irvine KD. Morphogen control of wing growth through the Fat signaling pathway. Dev Cell 2008, 15: 309-321.
58. Yu J, Zheng Y, Dong J, Klusza S, Deng WM and Pan D. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev Cell 2010, 18: 288-299.
59. Baumgartner R, Poernbacher I, Buser N, Hafen E and Stocker H. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev Cell 2010, 18: 309-316.
60. Genevet A, Wehr MC, Brain R, Thompson BJ and Tapon N. Kibra is a regulator of the Salvador/Warts/Hippo signaling network. Dev Cell 2010, 18: 300-308.
61. Hamaratoglu F, Willecke M, Kango-Singh M, Nolo R, Hyun E, Tao C and Jafar-Nejad H, et al. The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nat Cell Biol 2006, 8: 27-36.
62. Zhang N, Bai H, David KK, Dong J, Zheng Y, Cai J and Giovannini M, et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. Dev Cell 2010, 19: 27-38.
63. Zecca M and Struhl G. A feed-forward circuit linking wingless, fatdachsous signaling, and the warts-hippo pathway to Drosophila wing growth. PLoS Biol 2010, 8: e1000386.
64. Editors PLB. Vestigial rides a fat/dachsous wave in wing development. PLoS Biol 2010, 8: e1000389.
65. Zecca M and Struhl G. Control of Drosophila wing growth by the vestigial quadrant enhancer. Development 2007, 134: 3011-3020.
66. Zecca M and Struhl G. Recruitment of cells into the Drosophila wing primordium by a feed-forward circuit of vestigial autoregulation. Development 2007, 134: 3001-3010.
67. Herrlich P, Morrison H, Sleeman J, Orian-Rousseau V, Konig H, Weg-Remers S and Ponta H. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann NY Acad Sci 2000, 910: 106-118; discussion 18-20.
68. Wielenga VJ, Smits R, Korinek V, Smit L, Kielman M, Fodde R and Clevers H, et al. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J Pathol 1999, 154: 515-523.
69. Morrison H, Sherman LS, Legg J, Banine F, Isacke C, Haipek CA and Gutmann DH, et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes Dev 2001, 15: 968-980.
70. Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D and Montgomery EA, et al. Expression of Yes-associated protein in common solid tumors. Hum Pathol 2008, 39: 1582-1589.
71. Camargo FD, Gokhale S, Johnnidis JB, Fu D, Bell GW, Jaenisch R and Brummelkamp TR. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr Biol 2007, 17: 2054-2060.
72. Bottomly D, Kyler SL, McWeeney SK and Yochum GS. Identification of beta-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res 2010, 38: 5735-5745.
73. Konsavage WM, Jr, Kyler SL, Rennoll SA, Jin G and Yochum GS. Wnt/ beta-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells. J Biol Chem 2012, 287: 11730-11739.
74. Varelas X, Miller BW, Sopko R, Song S, Gregorieff A, Fellouse FA and Sakuma R, et al. The Hippo pathway regulates Wnt/beta-catenin signaling. Dev Cell 2010, 18: 579-591.
75. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL and Martin JF. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 2011, 332: 458-461.
76. Zhou D, Zhang Y, Wu H, Barry E, Yin Y, Lawrence E and Dawson D, et al. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA 2011, 108: E1312-E1320.
77. Imajo M, Miyatake K, Iimura A, Miyamoto A and Nishida E. A molecular mechanism that links Hippo signalling to the inhibition of Wnt/betacatenin signalling. EMBO J 2012, 31: 1109-1122.
78. Xin M, Kim Y, Sutherland LB, Qi X, McAnally J, Schwartz RJ and Richardson JA, et al. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal 2011, 4: ra70.
79. Silvis MR, Kreger BT, Lien WH, Klezovitch O, Rudakova GM, Camargo FD and Lantz DM, et al. Alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal 2011, 4: ra33.
80. Gottardi CJ and Gumbiner BM. Adhesion signaling: how beta-catenin interacts with its partners. Curr Biol 2001, 11: R792-R794.
81. Liu TX, Becker MW, Jelinek J, Wu WS, Deng M, Mikhalkevich N and Hsu K, et al. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. Nat Med 2007, 13: 78-83.
82. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993, 5: 806-811.
83. Perrais M, Chen X, Perez-Moreno M and Gumbiner BM. E-cadherin homophilic ligation inhibits cell growth and epidermal growth factor receptor signaling independently of other cell interactions. Mol Biol Cell 2007, 18: 2013-2025.
84. Kim NG, Koh E, Chen X and Gumbiner BM. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc Natl Acad Sci USA 2011, 108: 11930-11935.
85. Nejak-Bowen KN, Thompson MD, Singh S, Bowen WC, Jr, Dar MJ, Khillan J and Dai C, et al. Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant beta-catenin. Hepatology 2010, 51: 1603-1613.
86. Tan X, Behari J, Cieply B, Michalopoulos GK and Monga SP. Conditional deletion of beta-catenin reveals its role in liver growth and regeneration. Gastroenterology 2006, 131: 1561-1572.
87. Monga SP, Pediaditakis P, Mule K, Stolz DB and Michalopoulos GK. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 2001, 33: 1098-1109.
88. Lee KP, Lee JH, Kim TS, Kim TH, Park HD, Byun JS and Kim MC, et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 2010, 107: 8248-8253.
89. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y and Lauwers GY, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 2009, 16: 425-438.
90. Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA and Gayyed MF, et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 2007, 130: 1120-1133.
91. Apte U, Gkretsi V, Bowen WC, Mars WM, Luo JH, Donthamsetty S and Orr A, et al. Enhanced liver regeneration following changes induced by hepatocyte-specific genetic ablation of integrin-linked kinase. Hepatology 2009, 50: 844-851.
92. Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A and Pan D. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 2010, 24: 2383-2388.
93. Koch S, Nava P, Addis C, Kim W, Denning TL, Li L and Parkos CA, et al. The Wnt antagonist Dkk1 regulates intestinal epithelial homeostasis and wound repair. Gastroenterology 2011, 141: 259-268, 68 e1-8.
94. Zhao J, de Vera J, Narushima S, Beck EX, Palencia S, Shinkawa P and Kim KA, et al. R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Gastroenterology 2007, 132: 1331-1343.
95. Klaus A and Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 2008, 8: 387-398.
96. Barker N and Clevers H. Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 2006, 5: 997-1014.
97. Clevers H. Wnt/beta-catenin signaling in development and disease. Cell 2006, 127: 469-480.
98. Pan D. The hippo signaling pathway in development and cancer. Dev Cell 2010, 19: 491-505.
99. Bao Y, Hata Y, Ikeda M and Withanage K. Mammalian Hippo pathway: from development to cancer and beyond. J Biochem 2011, 149: 361-379.
100. Sasaki H, Kawano O, Endo K, Suzuki E, Yukiue H, Kobayashi Y and Yano M, et al. Human MOB1 expression in non-small-cell lung cancer. Clin Lung Cancer 2007, 8: 273-276.
101. Kosaka Y, Mimori K, Tanaka F, Inoue H, Watanabe M and Mori M. Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer. Int J Oncol 2007, 31: 333-338.
102. Minoo P, Zlobec I, Baker K, Tornillo L, Terracciano L, Jass JR and Lugli A. Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer. Mod Pathol 2007, 20: 331-338.
103. Cinar B, Fang PK, Lutchman M, Di Vizio D, Adam RM, Pavlova N and Rubin MA, et al. The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. EMBO J 2007, 26: 4523-4534.
104. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R and Liu YP, et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 2006, 124: 1169-1181.
105. Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH, Lin JT and Chen YL, et al. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp Cell Res 2009, 315: 2529-2538.
106. Zender L, Spector MS, Xue W, Flemming P, Cordon-Cardo C, Silke J and Fan ST, et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 2006, 125: 1253-1267.
107. Sansom OJ, Meniel VS, Muncan V, Phesse TJ, Wilkins JA, Reed KR and Vass JK, et al. Myc deletion rescues Apc deficiency in the small intestine. Nature 2007, 446: 676-679.
108. Reed KR, Athineos D, Meniel VS, Wilkins JA, Ridgway RA, Burke ZD and Muncan V, et al. B-catenin deficiency, but not Myc deletion, suppresses the immediate phenotypes of APC loss in the liver. Proc Natl Acad Sci USA 2008, 105: 18919-18923.
109. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012, 487: 330-337.
110. Polakis P. Drugging Wnt signalling in cancer. EMBO J 2012, 31: 2737-2746.
111. Liu-Chittenden Y, Huang B, Shim JS, Chen Q, Lee SJ, Anders RA and Liu JO, et al. Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev 2012, 26: 1300-1305.